Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ...
Upholding a man's conviction in a 39-year-old rape case, the Supreme Court has commiserated with the woman and her family, who had to wait so long for closure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback